Related Experiment Video
Updated: Aug 12, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Folic acid in folate-deficient patients with epilepsy
British Medical Journal
|December 12, 1970
Summary
This study found that folic acid supplementation did not significantly alter seizure frequency, behavior, or cognitive functions in epileptic patients with low folate levels. The treatment showed no notable improvements in these key areas.
Area of Science:
- Neurology
- Clinical Pharmacology
- Nutritional Science
Background:
- Epilepsy is a neurological disorder characterized by recurrent seizures.
- Low serum folate levels are observed in some epileptic patients, potentially impacting neurological function.
- Folic acid is essential for various bodily functions, including neurological health.
Purpose of the Study:
- To investigate the efficacy of folic acid supplementation in epileptic patients with low serum folate levels.
- To determine if folic acid treatment impacts seizure frequency, behavior, personality, or cognitive functions.
- To evaluate the effects of long-term folic acid supplementation in this patient group.
Main Methods:
- A double-blind, placebo-controlled trial was conducted.
- Fifty-one epileptic patients with serum folate levels below 3.6 ng/mL were enrolled.
- Participants received either 15 mg of folic acid daily or a placebo for at least six months, with 41 patients treated for over a year.
Main Results:
- No statistically significant changes were observed in the frequency of seizures among patients receiving folic acid compared to placebo.
- Folic acid supplementation did not lead to significant improvements in behavioral or personality assessments.
- Cognitive functions remained largely unchanged in both the folic acid and placebo groups.
Conclusions:
- Folic acid supplementation at 15 mg daily does not appear to be effective in reducing seizure frequency in epileptic patients with low serum folate levels.
- The study suggests that folic acid does not significantly influence behavior, personality, or cognitive performance in this specific patient population.
- Further research may be needed to explore other potential therapeutic roles or optimal dosages of folic acid in epilepsy management.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...